- Filed
- Apr 29, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 24, 2025 | 126.15M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $33.24M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $27.65M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.16M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.63M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $33.26M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $34.01M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $141.6M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $132.83M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $227.69M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $242.74M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 125.14M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $647K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$16.27M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $249.49M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $265.35M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.15 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.15 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $12.93M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$18.73M |